bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Time to Buy?

Shares of bioMerieux (OTCMKTS:BMXMF) gapped up prior to trading on Friday . The stock had previously closed at $109.61, but opened at $115.00. bioMerieux shares last traded at $115.00, with a volume of 1,012 shares trading hands.

Analysts Set New Price Targets

Separately, BNP Paribas Exane cut shares of bioMerieux to a “neutral” rating in a report on Wednesday, January 28th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.

bioMerieux Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.30 and a current ratio of 2.27. The business has a 50 day simple moving average of $120.34 and a 200-day simple moving average of $127.79.

About bioMerieux

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.